C618R mutation in exon 10 of the RET proto-oncogene in a kindred with multiple endocrine neoplasia type 2A and Hirschsprung's disease

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 7, 1996, Pages 2731-2733

  Caron, Philippe ^a   Attié, Tania ^c   David, Dina ^a   Amiel, Jeanne ^c   Brousset, Florence ^a   Roger, Patrick ^b   Munnich, Arnold ^c   Lyonnet, Stanislas ^c  

^a CHU RANGUEIL   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; PENTAGASTRIN; PROTEIN TYROSINE KINASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CODON; DNA SEQUENCE; EXON; FEMALE; GENE MUTATION; HETEROZYGOTE; HIRSCHSPRUNG DISEASE; HUMAN; HUMAN TISSUE; MALE; PEDIGREE ANALYSIS; PHEOCHROMOCYTOMA; POINT MUTATION; PRIORITY JOURNAL; PROTO ONCOGENE; RELATIVE; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA;

ADULT; CALCITONIN; CARCINOMA, MEDULLARY; DROSOPHILA PROTEINS; EXONS; FEMALE; HIRSCHSPRUNG DISEASE; HUMANS; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MUTATION; PEDIGREE; PENTAGASTRIN; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS;

EID: 0030013621     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.7.2731     Document Type: Article

References (21)

1. Mulligan LM, Ponder BAJ. 1995 Genetic basis of endocrine disease: multiple endocrine neoplasia type 2. J Clin Endocrinol Metab. 80:1989-1995.
2. Mulligan LM, Kwok JBJ, Healey CS, et al. 1993 Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458-460.
3. Donis-Keller H, Dou S, Chi D, et al. 1993 Mutations in the RET protooncogene are associated with MEN 2A and FMTC. Hum Mol Genet. 2:851-856.
4. Schuffenecker I, Billaud M, Calender A, et al. 1994 RET proto-oncogene mutations in French MEN 2A and FMTC families. Hum Mol Genet. 3:1939-1943.
5. Edery P, Lyonnet S, Mulligan LM, et al. 1994 Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature 367:378-380.
6. Romeo G, Ronchetto P, Luo Y, et al. 1994 Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 367:377-378.
7. Attié T, Pelet A, Edery P, et al. 1995 Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum Mol Genet 4:1381-1386.
8. Verdy M, Weber AM, Roy CC, Morin CL, Cadotte M, Brochu P. 1982 Hirschsprung's disease in a family with multiple endocrine neoplasia type 2. J Paediatr Gastroenterol Nutr. 1:603-607.
9. Frilling A, Becker H, Roeher HD. 1992 Unusual features in multiple endocrine neoplasia. Henry Ford Hosp Med J. 40:253-255.
10. Decker R, Shaha A, Talpos G, Saxe A, Wei J, Clark O. 1992 Long-term follow-up of a large North American kindred with multiple endocrine neoplasia type 2A. Surgery 112:1066-1073.
11. Mulligan LM, Eng C, Attié T, et al. 1994 Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. Hum Mol Genet. 3:2163-2167.
12. Hofstra R, Stelwagen T, Stulp R, et al. 1994 RET mutations in MEN 2 associated diseases. Am J Hum Genet. 55:A60.
13. Borst M, Peacock M, Minth C, Decker R. Mutational analysis of Hirschsprung's disease associated with multiple endocrine neoplasia type 2A. Fifth International Workshop on Multiple Endocrine Neoplasia, Stockholm, Sweden, 1994, p 65 (Abstract 609).
14. Chretien P, Blanchard L, Gaboury L, Lacroix A, Verdy M, Villeneuve L. 1994 Cosegregation of Hirschsprung's disease (HSCR) and a RET mutation in a French Canadian family with MEN 2A. Am J Hum Genet. 55:A357.
15. Tsai MS, Ledger GA, Khosla S, Gharib H, Thibodeau SN. 1994 Identification of multiple endocrine neoplasia, type 2 gene carriers using linkage analysis and analysis of the RET proto-oncogene. J Clin Endocrinol Metab. 78:1261-1264.
16. Mulligan LM, Eng C, Healey CS, et al. 1994 Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nature Genetics. 6:70-74.
17. Schuchardt A, D'Agati V, Larsson-Blomberg L, Costantini F, Pachnis V. 1994 Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367:380-383.
18. Santoro M, Carlomagno F, Romano A, et al. 1995 Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 267:381-383.
19. Pasini B, Borello MG, Greco A, et al. 1995 Loss of function effects of RET mutations causing Hirschsprung disease. Nature Genetics. 10:35-40.
20. Van Heyningen V. 1994 One gene -four syndromes. Nature, 367:319-320.
21. Dietrich WF, Lander ES, Smith JS, et al. 1993 Genetic identification of Mom-1, a major modifier locus affecting Min -induced intestinal neoplasia in the mouse. Cell 75:631-639.